pembrolizumab

Fri, 22 Apr 2022 12:54:58 -0400
Pembrolizumab
in combination with chemotherapy with or without bevacizumab, for the
treatment of adult patients with persistent, recurrent, or metastatic cervical
cancer whose tumors express PD-L1 (CPS=1) as determined by a validated
test.